This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schaaff, F.
Right arrow Articles by Bierbaum, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaaff, F.
Right arrow Articles by Bierbaum, G.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2002, p. 3540-3548, Vol. 46, No. 11
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.11.3540-3548.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

An Elevated Mutation Frequency Favors Development of Vancomycin Resistance in Staphylococcus aureus

Franziska Schaaff,* Andrea Reipert, and Gabriele Bierbaum

Institute of Medical Microbiology and Immunology, University of Bonn, D-53105 Bonn, Germany

Received 10 May 2002/ Accepted 16 August 2002

The emergence of intermediate vancomycin resistance, mainly in methicillin-resistant Staphylococcus aureus strains, has become a great concern. Thorough characterization of clinical and laboratory vancomycin-intermediately resistant S. aureus (VISA) strains identified multiple, resistance-associated changes most probably due to stepwise mutations. We hypothesized that an elevated mutation frequency as found, e.g., in mutator strains defective in DNA mismatch repair could allow rapid acquisition of adaptive mutations in the presence of vancomycin. We therefore subjected S. aureus RN4220 and its isogenic mutator strain, the mutS-knockout mutant RN4220{Delta}mutS, to a stepwise vancomycin selection procedure. Vancomycin resistance evolved much more quickly in the mutator background than in the wild type (5 versus 19 passages, respectively). In addition, a higher resistance level could be reached (MIC, 32 versus 4 µg/ml, respectively). The susceptibility to other antibiotics with the exception of teicoplanin remained unchanged. Concomitantly with increasing vancomycin resistance, a loss of phage typeability and differences in growth behavior as well as an improved ability to regrow at high vancomycin concentrations were observed. In conclusion, an elevated mutation rate in S. aureus led to the rapid development of vancomycin resistance, indicating that a high mutation frequency could be one of the factors that favor the emergence of vancomycin resistance in S. aureus.

* Corresponding author. Present address: University Children's Hospital Mainz, Langenbeckstr. 1, 55101 Mainz, Germany. Phone: 49-6131-173090. Fax: 49-6131-173401. E-mail: Schaaff{at}kinder.klinik.uni-mainz.de.

Antimicrobial Agents and Chemotherapy, November 2002, p. 3540-3548, Vol. 46, No. 11
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.11.3540-3548.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Harrison, F., Buckling, A. (2007). High relatedness selects against hypermutability in bacterial metapopulations. Proc R Soc B 274: 1341-1347 [Abstract] [Full Text]  
  • Cui, L., Lian, J.-Q., Neoh, H.-m., Reyes, E., Hiramatsu, K. (2005). DNA Microarray-Based Identification of Genes Associated with Glycopeptide Resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 49: 3404-3413 [Abstract] [Full Text]  
  • Trong, H. N., Prunier, A.-L., Leclercq, R. (2005). Hypermutable and Fluoroquinolone-Resistant Clinical Isolates of Staphylococcus aureus. Antimicrob. Agents Chemother. 49: 2098-2101 [Abstract] [Full Text]  
  • Palazzo, I. C. V., Araujo, M. L. C., Darini, A. L. C. (2005). First Report of Vancomycin-Resistant Staphylococci Isolated from Healthy Carriers in Brazil. J. Clin. Microbiol. 43: 179-185 [Abstract] [Full Text]  
  • Nilsson, A. I., Kugelberg, E., Berg, O. G., Andersson, D. I. (2004). Experimental Adaptation of Salmonella typhimurium to Mice. Genetics 168: 1119-1130 [Abstract] [Full Text]  
  • Koehl, J. L., Muthaiyan, A., Jayaswal, R. K., Ehlert, K., Labischinski, H., Wilkinson, B. J. (2004). Cell Wall Composition and Decreased Autolytic Activity and Lysostaphin Susceptibility of Glycopeptide-Intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 48: 3749-3757 [Abstract] [Full Text]  
  • Muthaiyan, A., Jayaswal, R. K., Wilkinson, B. J. (2004). Intact mutS in Laboratory-Derived and Clinical Glycopeptide-Intermediate Staphylococcus aureus Strains. Antimicrob. Agents Chemother. 48: 623-625 [Abstract] [Full Text]  
  • Kozitskaya, S., Cho, S.-H., Dietrich, K., Marre, R., Naber, K., Ziebuhr, W. (2004). The Bacterial Insertion Sequence Element IS256 Occurs Preferentially in Nosocomial Staphylococcus epidermidis Isolates: Association with Biofilm Formation and Resistance to Aminoglycosides. Infect. Immun. 72: 1210-1215 [Abstract] [Full Text]  
  • Willems, R. J., Top, J., Smith, D. J., Roper, D. I., North, S. E., Woodford, N. (2003). Mutations in the DNA Mismatch Repair Proteins MutS and MutL of Oxazolidinone-Resistant or -Susceptible Enterococcus faecium. Antimicrob. Agents Chemother. 47: 3061-3066 [Abstract] [Full Text]  
  • Jewell, N. A., Chen, R., Raices, R., Mansky, L. M. (2003). Nucleoside reverse transcriptase inhibitors and HIV mutagenesis. J Antimicrob Chemother 52: 547-550 [Full Text]  
  • Gustafson, J. E., O'Brien, F. G., Coombs, G. W., Malkowski, M. J., Grubb, W. B., Pfeltz, R. F., Wilkinson, B. J. (2003). Alterations in phage-typing patterns in vancomycin-intermediate Staphylococcus aureus. J Med Microbiol 52: 711-714 [Abstract] [Full Text]  
  • O'Neill, A. J., Chopra, I., Bierbaum, G., Reipert, A., Schaaff, F. (2003). Lack of Evidence for Involvement of Hypermutability in Emergence of Vancomycin-Intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 47: 1484-1485 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»